<DOC>
	<DOCNO>NCT01833988</DOCNO>
	<brief_summary>This study test hypothesis wearable automate bionic pancreas system automatically deliver insulin glucagon improve glycemic control vs. usual care young people type 1 diabetes 12-20 diabetes camp environment .</brief_summary>
	<brief_title>The Summer Camp Study : Blood Glucose Control With Bi-Hormonal Bionic Endocrine Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Age 1220 year type 1 diabetes least one year . Diabetes manage use insulin infusion pump rapid veryrapidacting insulin include insulin aspart ( NovoLog ) , insulin lispro ( Humalog ) , insulin glulisine ( Apidra ) least three month prior enrollment . Otherwise healthy ( mild chronic disease asthma allow well control require medication result exclusion ) . Unable provide inform assent Unable comply study procedure . Current participation another diabetesrelated clinical trial one primarily observational nature . Total daily dose ( TDD ) insulin &gt; 2 units/kg . Pregnancy ( positive urine HCG ) , plan become pregnant immediate future , sexually active without use contraception Hypoglycemia unawareness ( selfreported legal guardian report consistent lack hypoglycemia symptom BG &lt; 50 mg/dl ) End stage renal disease dialysis ( hemodialysis peritoneal dialysis ) . History prolong QT arrhythmia History congenital heart disease current know cardiac disease Acute illness ( nonvomiting viral illness ) exacerbation chronic illness type 1 diabetes time study . Seizure disorder history hypoglycemic seizures coma last five year Untreated inadequately treat mental illness ( indicator would include symptoms psychosis , hallucination , mania , psychiatric hospitalization last year ) , treatment second generation antipsychotic medication , know affect glucose regulation . Electrically powered implant ( e.g . cochlear implant , neurostimulators ) might susceptible radiofrequency interference . Use noninsulin , injectable ( e.g . exenatide , pramlintide ) oral ( e.g . thiazolidinediones , biguanides , sulfonylurea , meglitinides , dipeptidyl peptidase4 inhibitor , acarbose ) antidiabetic medication . History adverse reaction glucagon ( include allergy ) besides nausea vomiting . Unwilling unable completely avoid acetaminophen usual care closedloop BG control portion study . History eat disorder anorexia , bulimia , `` diabulemia '' omission insulin manipulate weight History intentional , inappropriate administration insulin lead severe hypoglycemia require treatment Any factor , opinion principal investigator , would interfere safe completion study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bionic pancreas</keyword>
	<keyword>artificial pancreas</keyword>
	<keyword>insulin</keyword>
	<keyword>glucagon</keyword>
	<keyword>continuous glucose monitoring ( CGM )</keyword>
	<keyword>outpatient</keyword>
	<keyword>insulin pump</keyword>
	<keyword>pediatrics</keyword>
	<keyword>child</keyword>
	<keyword>camp</keyword>
	<keyword>summer camp</keyword>
</DOC>